Gaugain L, Cawston H, Dubois de Gennes C, Sanchez Alvares J, et al. Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France. PLoS One 2023;18:e0280442.
PMID: 36652428